Form 8-K - Current report:
SEC Accession No. 0001193125-25-012211
Filing Date
2025-01-24
Accepted
2025-01-24 16:09:56
Documents
20
Period of Report
2025-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d833002d8k.htm   iXBRL 8-K 40428
2 EX-1.1 d833002dex11.htm EX-1.1 189658
3 EX-4.1 d833002dex41.htm EX-4.1 80083
4 EX-5.1 d833002dex51.htm EX-5.1 10528
5 EX-99.1 d833002dex991.htm EX-99.1 9688
6 EX-99.2 d833002dex992.htm EX-99.2 10472
10 GRAPHIC g833002dsp62.jpg GRAPHIC 6570
11 GRAPHIC g833002dsp64.jpg GRAPHIC 7239
  Complete submission text file 0001193125-25-012211.txt   574626

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA iron-20250121.xsd EX-101.SCH 2865
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20250121_lab.xml EX-101.LAB 17994
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20250121_pre.xml EX-101.PRE 11271
22 EXTRACTED XBRL INSTANCE DOCUMENT d833002d8k_htm.xml XML 3633
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 25554293
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)